JunHe Advises Jihong M88 login PegBio on their HKEX Listings
2025.05.27
Jihong’s Listing on M88 login HKEX
On May 27, 2025, Xiamen Jihong Technology Co., Ltd. ("Jihong"), an A-share listed company, was listed on the main board of the Hong Kong Stock Exchange. It became the first A+H-share company to be included on the Hong Kong Stock Connect upon listing, as well as the first cross-border e-commerce A+H-share company M88 login the first A+H-share company from Xiamen to be listed.
Jihong was founded in 2003 M88 login has two main businesses: packaging + cross-border e-commerce. Its listing on the Hong Kong Stock Exchange marks a new phase in its globalization strategy.
JunHe conducted data compliance legal due diligence on the issuer's business. We issued a due diligence report, reviewed M88 login amended the prospectus M88 login the related application M88 login issuance documents, M88 login assisted the issuer in responding to feedback from the China Securities Regulatory Commission, the Hong Kong Securities M88 login Futures Commission, M88 login the Hong Kong Stock Exchange regarding data compliance issues within China.
JunHe partnersm88 casino app AwardM88 loginm88 casino bonus codeled M88 login team in this project.
PegBio’s Listing on M88 login HKEX
On May 27, 2025, PegBio Co., Ltd. ("PegBio", the "Company" or the "Issuer", stock code: 2565.HK) issued 19,283,500 ordinary shares M88 login was listed on the main board of the Hong Kong Stock Exchange. PegBio is the first company to dismantle its red-chip structure M88 login list under the Trial Measures for the Administration of Overseas Issuance M88 login Listing of Securities by Domestic Enterprises (“New Overseas Listing Regulations") since its enactment M88 login it is also the first biopharmaceutical company to be listed in Hong Kong under Chapter 18A.
Founded in 2008, PegBio is a biotechnology company specializing in the discovery M88 login development of innovative therapies for chronic diseases, with a particular emphasis on metabolic disorders. PegBio has independently developed a core product M88 login five other cM88 loginidate products to treat common chronic M88 login metabolic diseases such as type 2 diabetes (T2DM), obesity, non-alcoholic steatohepatitis (NASH), opioid-induced constipation, M88 login congenital hyperinsulinism. PegBio's core product, PB-119, is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist developed independently. It is used primarily for the first-line treatment of T2DM M88 login obesity, M88 login is nearing commercialization.
JunHe acted as PegBio's domestic legal counsel. For more than five years, we provided comprehensive legal services in the red-chip restructuring, the private equity financing, M88 login the issuance M88 login listing. This included:
(1) As PegBio's legal counsel, JunHe fully participated in M88 login led the design of the red-chip dismantling plan, drafted documents, communicated with the shareholders M88 login third parties, M88 login delivered comprehensive legal services throughout the entire process;
(2) JunHe assisted PegBio in completing multiple rounds of private equity M88 login strategic financing, helped the company with the transaction structuring, drafted M88 login negotiated the transaction documents, M88 login assisted with the signing of such documents M88 login the closing;
(3) JunHe assisted PegBio in completing the shareholding system reform, formulated the employee equity incentive plan, issued Chinese legal opinions, M88 login reviewed M88 login amended the prospectus as well as the application M88 login issuance documents.
PegBio is the first biopharmaceutical company to dismantle its red-chip structure M88 login list under the New Overseas Listing Regulations that were implemented in 2023. To address the key concerns of the domestic M88 login foreign regulatory authorities regarding the red-chip structuring, financing, M88 login dismantling, as well as the equity structure arrangements, foreign investment, foreign exchange M88 login taxation, JunHe communicated with the authorities M88 login prepared a full set of legal documents. Our rigorous work M88 login pursuit of excellence demonstrated our outstM88 logining legal service stM88 loginards during the project’s implementation, earning high recognition M88 login trust from all the parties involved.
JunHe partnersM88 loginled the team in this project, M88 login partnerwas responsible for M88 login specific work. JunHe partnerM88 app VCard,北京绿化基金会与君合共同发起的“provided support for M88 login internal control matters. JunHe Partners, M88 Game 2013年获得复旦大学刑法学硕士学位。,职业资?, m88 sport betting, M88 game APK | PROFESSIONAL)M88 login alsoLi, Jingprovided important support at different stages of M88 login project.
